Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report
Authors:
- Stéphane KochSKStéphane Koch
- Solange Bresson-HadniSBSolange Bresson-Hadni
- Jean-Philippe MiguetJMJean-Philippe Miguet
- Jean-Pierre CrumbachJCJean-Pierre Crumbach
- Michel GilletMGMichel Gillet
- George-André MantionGMGeorge-André Mantion
- Bruno HeydBHBruno Heyd
- Dominique-Angèle VuittonDVDominique-Angèle Vuitton
- Anne MinelloAMAnne Minello
- Sabine KurtzSKSabine Kurtz
- European Collaborating CliniciansECEuropean Collaborating Clinicians
- 1 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 75 (6) , 856-863
Abstract
Alveolar echinococcosis (AE) of the liver is a rare and severe parasitic disease. It behaves like a slow-growing liver cancer, and liver transplantation (LT) has been proposed in advanced cases since 1985. The aim of this retrospective study was to collect all AE transplant cases in Europe, analyze the results, and specify the usefulness of LT for this unusual indication. A questionnaire was sent to 83 LT centers from July 1996 to December 1999. Sixty-five centers responded: 45 AE patients (mean age, 45.8 years) underwent an LT procedure at 16 LT centers. The mean interval between diagnosis and LT was 5 years. One patient died during the hepatectomy phase. Five-year survival was 71%. Five-year survival without recurrence was 58%. The nine early deaths were mostly related to bacterial or fungal infections, or both, in patients in bad condition when LT was performed. Six patients had a graft AE reinfection. Five late deaths were related directly to ongoing AE. In the other cases, benzimidazole (BZM) therapy seemed to stabilize AE residues. This unique experience indicates that LT is feasible for life-threatening AE. Specific management is needed to optimize the results: earlier decision for LT in incurable symptomatic biliary AE, pre- and post-LT BZM therapy, meticulous pre-LT evaluation to identify extrahepatic extension, and an immunosuppressive regimen kept to a minimum.Keywords
This publication has 17 references indexed in Scilit:
- Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literatureJournal of Antimicrobial Chemotherapy, 2000
- Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry studyThe Lancet, 2000
- A twenty-year history of alveolar echinococcosisEuropean Journal of Gastroenterology & Hepatology, 2000
- Primary disease recurrence after liver transplantation for alveolar echinococcosis: Long-term evaluation in 15 patientsHepatology, 1999
- Alveolar Echinococcosis in Humans: The Current Situation in Central Europe and the Need for CountermeasuresParasitology Today, 1999
- Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosisJournal of Hepatology, 1998
- Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosisHepatology, 1994
- Effects of cyclosporin a on the course of murine alveolar echinococcosis and on specific cellular and humoral immune responses against Echinococcus multilocularisInternational Journal for Parasitology, 1992
- Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: Report of 17 casesHepatology, 1991
- Filaricidal effects of Cyclosporin-A against Dipetalonema viteae in Mastomys natalensisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1984